Modified ghrelin polypeptides
US7385026B1 · kind B1 · utility
17Cited by
3References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2000 |
| Grant date | Jun 10, 2008 |
| Priority date | — |
| Expiry date | Aug 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K48/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a peptide-type compound which induces secretion of growth hormone and which has the activity of increasing the intracellular calcium ion concentration, wherein at least one amino acid is replaced by a modified amino acid and/or a non-amino acid compound, or a pharmaceutically acceptable salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.